CRC

Oncology·MeSH: Gastrointestinal Neoplasms

33 drugs in development·16 companies·13 clinical trials

Drug Pipeline by Phase

Approved(2)

Drug	Company
krazati	BRISTOL MYERS SQUIBB CO (BMY)
zaltrap	Sanofi (SNY)

Phase 3(8)

Drug	Company
Chemotherapy Regimen 1	BioNTech SE (BNTX)
Chemotherapy Regimen 2	BioNTech SE (BNTX)
Drug	Summit Therapeutics Inc. (SMMT)
folfox	Incyte Corp. (INCY)
Fruquintinib	IGM Biosciences, Inc. (IGMS)
Fruquintinib Combined With Chemotherapy	IGM Biosciences, Inc. (IGMS)
inca33890	Incyte Corp. (INCY)
PD-1 Antibody	IGM Biosciences, Inc. (IGMS)

Phase 2(15)

Drug	Company
350 mg leronlimab	CytoDyn Inc. (CYDY)
5 FU bolus	IGM Biosciences, Inc. (IGMS)
5 FU continuous	IGM Biosciences, Inc. (IGMS)
700 mg leronlimab	CytoDyn Inc. (CYDY)
BMS-986288	CytomX Therapeutics, Inc. (CTMX)
Chemotherapeutic Combinations	IGM Biosciences, Inc. (IGMS)
Floxuridine	BridgeBio Oncology Therapeutics, Inc. (BBOT)
H101	IGM Biosciences, Inc. (IGMS)
HCB101	IGM Biosciences, Inc. (IGMS)
ngm707	NGM BIOPHARMACEUTICALS INC (NGM)
PDS01ADC	IGM Biosciences, Inc. (IGMS)
PDS01ADC	BridgeBio Oncology Therapeutics, Inc. (BBOT)
PM8002	BioNTech SE (BNTX)
Target Therapy	IGM Biosciences, Inc. (IGMS)
Vincristine Sulfate Liposome	ENANTA PHARMACEUTICALS INC (ENTA)

Phase 1(6)

Drug	Company
ADI-270	Adicet Bio, Inc. (ACET)
LPM6690176	IGM Biosciences, Inc. (IGMS)
me-344	Lite Strategy, Inc. (LITS)
panitumumab	AMGEN INC (AMGN)
Tazemetostat	ENANTA PHARMACEUTICALS INC (ENTA)
varsetatug masetecan	CytomX Therapeutics, Inc. (CTMX)

Preclinical(1)

Drug	Company
VPS4A inhibitors (novel series)	Calithera Biosciences, Inc. (CALA)

Phase 2/Phase 3(1)

Drug	Company
granite	Gritstone bio, Inc. (GRTS)

BioSniper tracks 33 drugs in development for CRC across 16 companies.

There are 13 clinical trials targeting CRC tracked by BioSniper.

Full trial data, competitive analysis, and AI-powered pipeline tracking.